Track the 신테카바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 신테카바이오 has published 83 reports. Market capitalisation: €29.4bn. The latest transaction was filed on 15 July 2026 (Purchase). Among the most active insiders: 정종선. Every trade is free.
82
Insider Decl.
n/a
Thresholds
n/a
43 ops.
Buy Volume
n/a
9 ops.
Sell Volume
Fundamental score
Ranked 24,068 of 29,063 companies
28.6
score / 100
Value
5
Quality
52
FCF yld-36%
Earn yld-59%
EV/EBITDA·
ROE-59%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.